Table:
begin	end	state
1	20	cytoplasmic
21	47	transmembrane
48	62	non-cytoplasmic
63	83	transmembrane
84	90	cytoplasmic
91	110	transmembrane
111	115	non-cytoplasmic
116	137	transmembrane
138	149	cytoplasmic
150	169	transmembrane
170	178	non-cytoplasmic
179	198	transmembrane
199	257	cytoplasmic
258	281	transmembrane
282	296	non-cytoplasmic
297	318	transmembrane
319	328	cytoplasmic
329	348	transmembrane
349	359	non-cytoplasmic
360	384	transmembrane
385	403	cytoplasmic
404	422	transmembrane
423	427	non-cytoplasmic
428	446	transmembrane
447	473	cytoplasmic

Input:
>WP_008806353.1 NCBI__GCF_000025465.1:WP_008806353.1
MTSISNDSALTPRTQRDTRRMNWFVSIAAAVAGLLFGLDIGVISGALPFITDHFTLSSQL
QEWVVSSMMLGAAIGALFNGWLSFRLGRKYSLMAGAVLFVAGSIGSAFAASVEVLLIARV
VLGVAVGIASYTAPLYLSEMASENVRGKMISMYQLMVTLGIVLAFLSDTAFSYSGNWRAM
LGVLALPAVILIILVVFLPNSPRWLAEKGRHIEAEEVLRMLRDTSEKARDELNEIRESLK
LKQGGWALFKVNRNVRRAVFLGMLLQAMQQFTGMNIIMYYAPRIFKMAGFTTTEQQMIAT
LVVGLTFMFATFIAVFTVDKAGRKPALKIGFSVMALGTLVLGYCLMQFDNGTASSGLSWL
SVGMTMMCIAGYAMSAAPVVWILCSEIQPLKCRDFGITCSTTTNWVSNMIIGATFLTLLD
AIGAAGTFWLYTVLNVAFIGVTFWLIPETKNVTLEHIERNLMAGEKLRNIGNR

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server